shRNAs and siRNAs can be used to successfully knock down the expression of any specific protein in a given cell line or organism. The utility of one over the other is debarable, but there are merits to using one for therapeutic applications in a living organism. Which of the two methods is likely to be more advantageous in the long-term and what is one of its limitations?